advantan ointment
bayer pharma ag bayer pharma ag 13342 berlin germany - methylprednisolone aceponate - ointment - ointment tube containing 15 g. - plain potent corticosteroids (group iii) for
betason ointment
shalina healthcare kenya limited shalina building - betamethasone valerate ointment - ointment - 0.10% - plain potent corticosteroids (group iii) for
sorid ointment
ochoa laboratories ltd 430 mzz. f gundecha indl. complex akurli road - calcipotriol & betamethasone dipropioante ointment - ointment - calcipotriol monohydrate bp 50 mcg betamethasone - other chemotherapeutics for topical use
tobrex eye ointment
novartis pharmaceuticals australia pty ltd - tobramycin, quantity: 3 mg/g - eye ointment - excipient ingredients: liquid paraffin; white soft paraffin; chlorobutanol hemihydrate - indications as at 02 may 1984 : tobrex is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobrex.
chlorsig 1% chloramphenicol 10 mg/g eye ointment tube
aspen pharma pty ltd - chloramphenicol, quantity: 10 mg/g - eye ointment - excipient ingredients: wool fat; liquid paraffin; white soft paraffin - indications as at 29 january 2001: for the treatment of bacterial conjunctivitis and other superficial ocular infections caused by chloramphenicol-sensitive organisms.
rectozorin ointment
teva israel ltd - benzocaine; bismuth oxychloride; menthol; thymol biiodide; zinc oxide - ointment - zinc oxide 10 %w/w; benzocaine 4 %w/w; menthol 0.25 %w/w; bismuth oxychloride 8 %w/w; thymol biiodide 2 %w/w - bismuth preparations, combinations - bismuth preparations, combinations - symptomatic relief of pain and discomfort in irritated anorectal tissues in: hemorrhoids, proctitis, papillitis, cryptitis, fissures and following anorectal surgery.
eumovate ointment
glaxo smith kline (israel) ltd - clobetasone butyrate - ointment - clobetasone butyrate 0.05 %w/w - clobetasone - clobetasone - eumovate ointment is a moderately potent topical corticosteroid indicated for adults, elderly, children and infants for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses.these include the following:- atopic dermatitis- irritant or allergic contact dermatitis- seborrhoeic dermatitis- nappy rash- photodermatitis- otitis externa- prurigo nodularis- insect bite reactionseumovate may be used as maintenance therapy between courses of one of the more potent topical steroids.
betnovate ointment
glaxo smith kline (israel) ltd - betamethasone as valerate - ointment - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - betamethasone valerate is a potent topical corticosteroid indicated for adults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses.these include the following:atopic dermatitis (including infantile atopic dermatitis)nummular dermatitis (discoid eczema)prurigo nodularispsoriasis (excluding widespread plaque psoriasis)lichen simplex chronicus (neurodermatitis) and lichen planusseborrhoeic dermatitisirritant or allergic contact dermatitisdiscoid lupus erythematosusadjunct to systemic steroid therapy in generalised erythroderma
elocom ointment
organon pharma israel ltd., israel - mometasone furoate - ointment - mometasone furoate 0.1 % - mometasone - mometasone - for the relief of the inflammatory and pruritic manifestations of corticosteroid - responsive dermatoses such as psoriasis and atopic dermatitis.
dermovate ointment
glaxo smith kline (israel) ltd - clobetasol 17- propionate - ointment - clobetasol 17- propionate 0.05 %w/w - clobetasol - clobetasol - clobetasol is a very potent topical corticosteroid indicated for adults, elderly and children over 1 year for the short term treatment only of more resistant inflammatory and pruritic manifestations of steroid responsive dermatoses unresponsive to less potent corticosteroids. these include the following:• psoriasis (excluding widespread plaque psoriasis)• recalcitrant dermatoses •lichen planus• discoid lupus erythematosus • other skin conditions which do not respond satisfactorily to less potent steroids.